Science at the Eijkman Institute
Strategic Investment in Fundamental Research
| The Eijkman Institute carries out fundamental research of strategic biomedical importance. The Institute research programs had developed following a strategy to ensure maximal scientific performance from the start. It follows a progressive recruitment and manpower development plan, and capitalizes on similarities in scientific strategies and technologies. Some of the current research activities are summarized below. |
| CLICK PICTURE FOR DETAIL DESCRIPTION | |
 | Energy Transduction, Disease and Ageing. Defective energy transduction is the cause of many diseases, including various neurological abnormalities, blindness, deafness and diabetes mellitus; it plays an important role in the ageing process and in degenerative diseases. |
 | Human Genome Diversity. Taking advantage of the huge human genetic resource of Indonesia, as reflected by its many ethnic populations, this fundamental research activity is strategic as the basis for disease genes discovery, with their medical and biotechnological applications. |
 | Red Blood Cell Genetic Disorders. The definition of mutations underlying diseases such as the thalassemias in the ethnically diverse Indonesian populations, the biochemical and clinical manifestations of such mutations, and knowledge applications in prenatal diagnosis are important for the management of these most common genetic disorders. |
 | Genetic Variants and Resistance to Malaria. The molecular mechanisms by which polymorphic variants of the red blood cells confer resistance towards malaria is not only of interest for its medical application but also of a fundamental biological importance. |
 | The Molecular Basis of Malaria Infection. Includes studies on the molecular basis of resistance to antimalaria drugs and of cerebral malaria, and the development of new diagnostic methods and vaccines. |
 | Hepatitis Viruses and their Genetic Diversity. The molecular characterization of hepatitis viruses and their variation, in particular of Hepatitis B and C, and the understanding of their pathogenic mechanism, is of strategic importance for diagnostic, vaccination and treatment strategies. |
 | Bridging Basic Research and Industry. The R&D unit of the Institute has a special task to develop research discoveries for their release to the industry, currently focusing on diagnostics and collaborating with PT BioFarma in vaccine development. |
Supporting Facilities
 | Microscopy Laboratory. ..... |
| [ Image not found ] | Bioinformatics Laboratory. ..... |
 | Library. ..... |
